all report title image

PERIODIC FEVER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Periodic Fever Market, By Disease Type (Familial Mediterranean Fever, TNF Receptor–Associated Periodic Syndrome, Mevalonate Kinase Deficiency, Cryopyrin-Associated Periodic Syndromes, PFAPA Syndrome, and Systemic Autoinflammatory Periodic Fevers), By Treatment Type (Biologic Therapies, Corticosteroids, Colchicine Therapy, NSAIDs & Symptomatic Treatments, Immunosuppressants, and Emerging Targeted Therapies & Gene-based Treatments), By Route of Administration (Injectable, Oral, and Intravenous Infusion), By Diagnosis Type (Genetic Testing, Laboratory & Biomarker Testing, Clinical Diagnosis, and Imaging & Supportive Diagnostic Methods), By Patient Group (Pediatric Patients and Adult Patients), By End User (Hospitals, Specialty & Rheumatology Clinics, Ambulatory Surgical Centers, and Homecare Settings), By Distribution Channel (Online and Offline), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

  • Published In: 04 Feb, 2026
  • Code: CMI9297
  • Page number: 152
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026 - 2033
Ingographics Image

 Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Periodic Fever Market, By Disease Type
      • Global Periodic Fever Market, By Treatment Type
      • Global Periodic Fever Market, By Route of Administration
      • Global Periodic Fever Market, By Diagnosis Type
      • Global Periodic Fever Market, By Patient Group
      • Global Periodic Fever Market, By End User
      • Global Periodic Fever Market, By Distribution Channel
      • Global Periodic Fever Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trends
  4. Global Periodic Fever Market, By Disease Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Familial Mediterranean Fever
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • TNF Receptor–Associated Periodic Syndrome
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Mevalonate Kinase Deficiency
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Cryopyrin-Associated Periodic Syndromes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • PFAPA Syndrome
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Systemic Autoinflammatory Periodic Fevers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  5. Global Periodic Fever Market, By Treatment Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Biologic Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Colchicine Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • NSAIDs & Symptomatic Treatments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Immunosuppressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Emerging Targeted Therapies & Gene-based Treatments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  6. Global Periodic Fever Market, By Route of Administration, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Intravenous Infusion
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  7. Global Periodic Fever Market, By Diagnosis Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Genetic Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Laboratory & Biomarker Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Clinical Diagnosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Imaging & Supportive Diagnostic Methods
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  8. Global Periodic Fever Market, By Patient Group, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pediatric Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Adult Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  9. Global Periodic Fever Market, By End User, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Specialty & Rheumatology Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Homecare Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  10. Global Periodic Fever Market, By Distribution Channel, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Online
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Offline
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  11. Global Periodic Fever Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  12. Competitive Landscape

    • Novartis
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Swedish Orphan Biovitrum Sobi
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Regeneron Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Hikma Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Janssen Biotech Johnson and Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Roche
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • UCB
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Dr Reddys Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  13. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  14. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Periodic Fever Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.